Tumor Suppressor Genes
Functional evidence obtained from somatic cell fusion studies indicated that a group of genes from normal cells might replace or correct a defective function of cancer cells. Tumorigenesis that could be initiated by two mutations was established by the analysis of hereditary retinoblastoma, which le...
Sábháilte in:
| Rannpháirtithe: | |
|---|---|
| Formáid: | Leictreonach Caibidil leabhair |
| Teanga: | Béarla |
| Foilsithe / Cruthaithe: |
IntechOpen
2012
|
| Ábhair: | |
| Rochtain ar líne: | DOAB: download the publication DOAB: description of the publication |
| Clibeanna: |
Cuir clib leis
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|
| Achoimre: | Functional evidence obtained from somatic cell fusion studies indicated that a group of genes from normal cells might replace or correct a defective function of cancer cells. Tumorigenesis that could be initiated by two mutations was established by the analysis of hereditary retinoblastoma, which led to the eventual cloning of RB1 gene. The two-hit hypothesis helped isolate many tumor suppressor genes (TSG) since then. More recently, the roles of haploinsufficiency, epigenetic control, and gene dosage effects in some TSGs, such as P53, P16 and PTEN, have been studied extensively. It is now widely recognized that deregulation of growth control is one of the major hallmarks of cancer biological capabilities, and TSGs play critical roles in many cellular activities through signaling transduction networks. This book is an excellent review of current understanding of TSGs, and indicates that the accumulated TSG knowledge has opened a new frontier for cancer therapies. |
|---|---|
| Cur síos fisiciúil: | 1 electronic resource (346 p.) |
| ISBN: | 1337 9789533078793 9789535167440 |
| Rochtain: | Open Access |